Spotlight: Supporting cancer patients in community pharmacy

Migraine Research Foundation. Migraine Facts. https://bit.ly/39vl218

Fookes C (Tech Ed). Migraine. In Healthcare Handbook 2019–2020. Auckland, NZ: The Health Media Ltd; 2019.

Neurological Foundation. Migraine. https://bit.ly/2xy7BjM

Mayo Clinic. Migraine. https://mayocl.in/3dE2dMz

Web MD. Food Triggers for Migraines. January 2019. https://wb.md/2JpwnoU

The Migraine Trust. Common triggers. https://bit.ly/3dBflC5

New Zealand Formulary. 4.7.4.1: Treatment of acute migraine. March 2020. https://nzf.org.nz/nzf_2557

Derry S, Moore RA. Paracetamol (acetaminophen) with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev 2013;(4):CD008040.

Kirthi V, Derry S, Moore RA. Aspirin with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev 2013;(4):CD008041.

Rabbie R, Derry S, Moore R. Ibuprofen with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev 2013;(4):CD008039.

Derry S, Rabbie R, Moore R. Diclofenac with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev 2013;(4):CD008783.

Derry CJ, Derry S, Moore RA. Sumatriptan (oral route of administration) for acute migraine attacks in adults. Cochrane Database Syst Rev 2012;2:CD008615.

Derry CJ, Derry S, Moore RA. Sumatriptan (subcutaneous route of administration) for acute migraine attacks in adults. Cochrane Database Syst Rev 2012;2:CD009665.

Láinez MJ. Rizatriptan in the treatment of migraine. Neuropsychiatr Dis Treat 2006;2(3):247–59.

Medsafe. Consent to distribute Cafergot tablets (ergotamine tartrate 1 mg + caffeine 100 mg) will be prohibited under Section 36 of the Medicines Act 1981 on 1 May 2020. November 2019. https://bit.ly/3dD0jvz

The Migraine Trust. CGRP pathway monoclonal antibodies. https://bit.ly/3aw9agW

Medsafe. Medsafe Product Detail: Aimovig Solution for injection, 70 mg/mL (Prescription). May 2019. https://bit.ly/2QS09ac

The Migraine Trust. Medication-overuse headache. https://bit.ly/2UsTbL2

Facchinetti F, Sances G, Borella P, et al. Magnesium prophylaxis of menstrual migraine: effects on intracellular magnesium. Headache 1991;31(5):298–301.

Peikert A, Wilimzig C, Köhne-Volland, R. Prophylaxis of migraine with oral magnesium: Results from a prospective, multicenter, placebo-controlled and double-blind randomized study. Cephalalgia 1996;16(4):257–63.

Pfaffenrath V, Wessely P, Meyer C, et al. Magnesium in the prophylaxis of migraine—a double-blind placebo-controlled study. Cephalalgia 1996;16(6):436–40.

Murphy JJ, Heptinstall S, Mitchell JRA. Randomised double-blind placebo-controlled trial of feverfew in migraine prevention. Lancet 1988;2(8604):189–92.

Johnson ES, Kadam NP, Hylands DM, et al. Efficacy of feverfew as prophylactic treatment of migraine. Br Med J (Clin Res Ed) 1985;291(6495):569–73.

Rozen TD, Oshinsky ML, Gebeline CA, et al. Open label trial of coenzyme Q10 as a migraine preventive. Cephalalgia 2002;22(2):137–41.

Sándor PS, Di Clemente L, Coppola G, et al. Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial. Neurology 2005;64(4):713–15.

Schoenen J, Jacquy J, Lenaerts M. Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial. Neurology 1998;50(2):466–70.